Last update :
18/07/2024
General anesthetic   Pentobarbital  
suppository
Stability of pharmaceutical preparations Stability of mixtures Factors which affect stability Compatibility References pdf

suppository
Stability of pharmaceutical preparations   suppository   Stability of pharmaceutical preparations : Pentobarbital     
Container Origine excipient Temperature Storage Duration of stability References
Not specified powder 30 mg
® = ?
Witepsol® W25 1,07 g
2-8°C Protect from light
288 Day
4750

Not specified powder 40 mg
® = ?
Witepsol® W25 1,06 g
2-8°C Protect from light
288 Day
4750

Not specified powder 50 mg
® = ?
Witepsol® W25 1,05 g
2-8°C Protect from light
288 Day
4750

Not specified powder 60 mg
® = ?
Witepsol® W25 1,04 g
2-8°C Protect from light
288 Day
4750

Not specified powder 30 mg
® = ?
Witepsol® W25 0,861 g
oleic acid 0,223 g
2-8°C Protect from light
196 Day
4750

Not specified powder 40 mg
® = ?
Witepsol® W25 0,830 g
oleic acid 0,253 g
2-8°C Protect from light
196 Day
4750

Not specified powder 50 mg
® = ?
Witepsol® W25 0,801 g
oleic acid 0,280 g
2-8°C Protect from light
196 Day
4750

Not specified powder 60 mg
® = ?
Witepsol® W25 0,775 g
oleic acid 0,304 g
2-8°C Protect from light
196 Day
4750


  Mentions Légales